Abstracts tagged "sarcoidosis and uveitis"

Abstract Number: 2265 • 2018 ACR/ARHP Annual Meeting
Lymphocyte Immunophenotyping and CD4/CD8 Ratio in Cerebrospinal Fluid for the Diagnosis of Sarcoidosis-Related Uveitis
Romain Paule¹, Laure Denis¹, Nicolas Chapuis², Julien Rohmer¹, Jonathan London³, Clemence Bonnet⁴, Anthony Chauvin⁵, Luc Mouthon¹, Dominique Monnet⁴, Claire Le Jeunne¹, Antoine Brezin⁶ and Benjamin Terrier⁷, ¹National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Internal medicine, France, Paris, France, ²Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Biological Hematology, France, Paris, France, ³Internal Medecine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁴Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, ⁵Emergency Département, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France; Faculté de Médecine, Université Diderot, Paris, France, Paris, France, ⁶Ophtalmology, Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, ⁷Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France
Background/Purpose: The diagnostic workup of uveitis is a challenge due to the wide range of diagnoses and the lack of a well-codified diagnostic procedure. Underlying…
Abstract Number: 2266 • 2018 ACR/ARHP Annual Meeting
Serum 1,25(OH)2 Vitamin D and 25(OH) Vitamin D Ratio for the Diagnosis of Sarcoidosis-Related Uveitis
Julien Rohmer¹, Jérôme Hadjadj², Amina Bouzerara³, Sawsen Salah⁴, Romain Paule⁵, Matthieu Groh⁶, Philippe Blanche⁷, Luc Mouthon⁸, Dominique Monnet⁴, Claire Le Jeunne⁹, Jean Guibourdenche¹⁰, Antoine Brezin¹¹ and Benjamin Terrier¹², ¹National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Internal medicine, France, Paris, France, ²Department of Internal Medicine, National Referral Center for Rare Autoimmune and Systemic Diseases, Hospital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Team Neutrophils and Vasculitis, INSERM U1016, Cochin Institute, Paris, France, Paris, France, ³Service d'Hormonologie, Hôpital Cochin, Paris, France, ⁴Ophtalmology, Cochin Hospital, Paris, France, ⁵Department of Internal Medicine, Department of Internal Medicine, Cochin University Hospital, Paris, France, ⁶Internal Medicine, Foch, Suresnes, France, ⁷Internal Medicine, Cochin Hospital, Paris, France, ⁸Department of Internal Medicine, INSERM Unité 1016, Centre de Référence pour les Maladies Auto-immunes Rares, National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France, ⁹Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ¹⁰Hormonology department, Cochin Hospital, Paris, France, ¹¹Ophtalmology, Referral Center for Rare Ophthalmological Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, ophtalmology, France, Paris, France, ¹²National Referral Center for Rare Systemic Autoimmune Diseases, Paris Cochin, France, Paris, France
Background/Purpose: The diagnostic workup of uveitis is challenging, with 30 to 50% of cases remaining of undetermined etiology despite multiple investigations. Sarcoid granuloma-related increase of…
Abstract Number: 1161 • 2017 ACR/ARHP Annual Meeting
Clinical Characteristics of Ocular Sarcoidosis: A Population Based Study 1976-2013
Patompong Ungprasert¹, Andrea Tooley², Cynthia S. Crowson³, Eric L. Matteson⁴ and Wendy M. Smith⁵, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Opthalmology, Mayo Clinic, Rochester, MN, ³Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁴Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁵Department of Ophthalmology, Mayo Clinic, Rochester, MN
Clinical Characteristics of Ocular Sarcoidosis: A Population Based Study 1976-2013Background/Purpose: To characterize the epidemiology and clinical characteristics of ocular involvement in patients with systemic sarcoidosis.Methods:…
Abstract Number: 1170 • 2017 ACR/ARHP Annual Meeting
High Output Flow Cytometry Array Classifies Subjects with Uveitis Due to Behcet’s Disease and Sarcoidosis
Johannes Nowatzky¹, Ezra Resnick², Julia Manasson³, Cristy Stagnar¹ and Olivier Manches⁴, ¹Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, ²Google Inc., New York, NY, ³Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ⁴EFS Rhône-Alpes-Auvergne "Immunobiology and Immunotherapy in Chronic Diseases", INSERM - French National Institute of Health and Medical Research, Grenoble, France
Background/Purpose: The information content of multi-parametric flow cytometry-based immune-phenotyping experiments is routinely underexploited given the paucity of adequate tools and strategies for large-scale unbiased data…
Abstract Number: 1334 • 2016 ACR/ARHP Annual Meeting
Contribution of Diagnostic Investigations in the Management of Uveitis: Retrospective Analysis of 300 Patients
Jérôme Hadjadj¹, Thibault Chapron², Manal Assala¹, Sawsen Salah², Bertrand Dunogue¹, Matthieu Groh³, Philippe Blanche¹, Luc Mouthon⁴, Dominique Monnet², Claire Le Jeunne⁴, Antoine Brezin² and Benjamin Terrier³, ¹Internal Medicine, Cochin Hospital, Paris, France, ²Ophtalmology, Cochin Hospital, Paris, France, ³National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, ⁴Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France
Background/Purpose: Uveitis represents a diagnostic and therapeutic challenge, as well as an economic one, due to its heterogeneous presentation, multiple underlying causes and lack of…
Abstract Number: 1393 • 2015 ACR/ARHP Annual Meeting
Diagnostic Categorization of Ocular Sarcoidosis Based on the International Criteria Proposed By the First International Workshop on Ocular Sarcoidosis. a Case Series of 11 Spanish Patients
Carlos Francisco Meneses Villalba¹, Olga Maiz Alonso¹, Ana Blanco², César Antonio Egües Dubuc¹, Miren Uriarte Ecenarro¹, Nerea Errazquin Aguirre¹, Jesus A. Valero¹ and Joaquin Maria Belzunegui Otano¹, ¹Rheumatology, Donostia University Hospital, Donostia, Spain, ²Ophthalmology, Donostia University Hospital, Donostia, Spain
Background/Purpose: Sarcoidosis is a multisystemic disorder of unknown cause. About 30-60% of patients have ocular involvement consistent in bilateral uveitis. Recently, the clasification criteria proposed by…
Abstract Number: 1134 • 2014 ACR/ARHP Annual Meeting
Role of NOD2 Pathway in Sarcoidosis Cases with Characteristics of Blau Syndrome
Gerard Dumancas¹, Indra Adrianto², Albert M. Levin³, Michael C. Iannuzzi⁴, Benjamin A. Rybicki³ and Courtney Montgomery⁵, ¹Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ²825 Ne 13th St. Ms 57, Oklahoma Medical Research Foundation, Oklahoma City, OK, ³Department of Public Health Sciences, Henry Ford Health System, Detroit, MI, ⁴Department of Medicine, SUNY Upstate Medical University, Syracuse, NY, ⁵Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Blau syndrome (BS) is a rare autosomal dominant, autoinflammatory syndrome characterized by the clinical triad symptoms of symmetric arthritis, dermatitis, and granulomatous recurrent uveitis,…
Abstract Number: 2013 • 2013 ACR/ARHP Annual Meeting
Biologic Therapy In Refractory Uveitis Of Sarcoidosis. Multicenter Study Of 16 Patients
Javier Loricera¹, Vanesa Calvo-Río², Ricardo Blanco³, Marina Mesquida⁴, Alfredo M. Adan⁴, JM Herreras⁵, A Aparicio⁶, MJ Moreno Ramos⁷, MJ Moreno Martínez⁷, LF Linares Ferrando⁷, M Hernández Martínez⁸, D Peitado-Lopez⁹, Miguel Cordero-Coma¹⁰, Jl García Serrano¹¹, Norberto Ortego¹¹, O Maíz¹², A Blanco¹³, Juan Sánchez-Bursón¹⁴, S González-Suárez¹⁵, Alejandro Fonollosa¹⁶, Montserrat Santos-Gómez², F. Ortiz-Sanjuán¹ and Miguel Angel González-Gay¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander. Spain, Santander, Spain, ²Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, ³Hospital Marques de Valdecilla, Santander, Spain, ⁴Ophthalmology, Hospital Clínic of Barcelona, Barcelona, Spain, ⁵Hospital Universitario, IOBA. Valladolid, Valladolid, Spain, ⁶Rheumatology., Hospital de Toledo., Toledo, Spain, ⁷Rheumatology, Hospital Clínico Universitario Virgen de la Arrixaca. Murcia, Murcia, Spain, ⁸Ophthalmology, Hospital Clínico Universitario Virgen de la Arrixaca. Murcia, Murcia, Spain, ⁹Rheumatology, Hospital Universitario La Paz Madrid, Madrid, Spain, ¹⁰Ophthalmology, Hospital de León. Spain, León, Spain, ¹¹Hospital San Cecilio. Granada, Granada, Spain, ¹²Rheumatology, Hospital Donosti San Sebastian, San Sebastián, Spain, ¹³Ophthalmology., Hospital Donosti San Sebastian, San Sebastián, Spain, ¹⁴Hospital de Valme. Sevilla, Sevilla, Spain, ¹⁵Rheumatology., Hospital Cabueñes, Gijón, Gijón, Spain, ¹⁶Ophtalmology Service, Hospital de Cruces. Bilbao, Bilbao, Spain
Background/Purpose: Uveitis related to sarcoidosis is a potentially severe complication. Corticosteroids are the first line of treatment. In refractory cases or in those with unacceptable…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].